openPR Logo
Press release

L-Hydroxyphenylalanine Market Will hit at a CAGR of 3.50% from 2018 to 2028

07-19-2018 04:43 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

L-Hydroxyphenylalanine Market Will hit at a CAGR of 3.50% from

As a part of the amino acid family, use of L-hydroxyphenylalanine as an energy providing aromatic ingredient has significantly fuelled its demand across the dietary supplement and nutraceuticals space. This factor continues to remain instrumental in driving the growth of the L-hydroxyphenylalanine market during the period of forecast. Moreover, various pharmaceutical uses of L-hydroxyphenylalanine including its application in formulations to treat Parkinson’s disease, Alzheimer’s disease and cancer are also expected to contribute to the overall growth of the L-hydroxyphenylalanine market. Being recognized as GRAS (Generally Recognized as Safe) by the FDA, the use of L-hydroxyphenylalanine in food and beverage sector has also witnessed significant growth in recent times.

A new research study by Fact.MR reveals growth pathways for L-hydroxyphenylalanine from a global viewpoint during the period of forecast, 2018-2028. The report includes estimations that reflect global sales of L-hydroxyphenylalanine which are expected to cross US$ 1,500 Mn by end of the year of assessment (2028). The sales of L-hydroxyphenylalanine are expected to remain concentrated in the developed countries of North America and emerging economies in the Asia Pacific excluding Japan (APEJ) region, given the increasing demand for L-hydroxyphenylalanine in anti-ageing creams and as effective adjuvant in cancer treatment in these regions.

L-Hydroxyphenylalanine Market: Use of L-Hydroxyphenylalanine in Dietary Supplements to Spearhead in the Coming Years

Dietary supplements and nutraceuticals have witnessed significant proliferation across various countries worldwide, given the increasing consumer awareness regarding healthy diet and exercise. Moreover, the growing number of individuals participating in heavy physical activities has further complemented the use of supplements for enhancing muscle growth. Being an amino acid, L-hydroxyphenylalanine as an energy ingredient has witnessed high demand in the production of health supplements, which is expected to fuel the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: High Prevalence of Parkinson’s Disease to Call for Efficient Treatment Solutions

Parkinson’s disease is directly associated with low blood pressure and orthostatic hypotension, that translates into need for effective pharmaceutical formulations that facilitate high energy flow and increase the heart rate. That said, L-hydroxyphenylalanine plays an imperative role in producing significant amount of energy that improves parkinsonian orthostatic hypotension and raises blood pressure, causing the shaking of body to reduce drastically. This factor coupled with increasing cases of Parkinson’s disease across the globe has enhanced the demand of L-hydroxyphenylalanine, in turn contributing to the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: Melanoma Treatment to Create Potential Avenues

Treatment of melanoma is expected to pave significant pathways for growth of the L-hydroxyphenylalanine market, as studies reveal the potential of the L-hydroxyphenylalanine in production of melanin. The Federation of American Societies for Experimental Biology Journal has highlighted the link between mitochondrial function and production of melanin in cancerous skin cells. Post examination revealed that the rate of Reactive Oxygen Species generation in darker cells were high as compared to medium and low level pigments. Provision of L-hydroxyphenylalanine as a building block for melanin production, has been used to activate medium and light cells to increase the production of melanin. This concept is expected to trigger coupling cellular adaptation and stress signaling through ROS signaling, which in turn has the potential to support development of anti-cancer drugs for treating melanoma. This approach is expected provide substantial growth opportunities for the use L-hydroxyphenylalanine, consequently fuelling the growth of the L-hydroxyphenylalanine market during the forecast period.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release L-Hydroxyphenylalanine Market Will hit at a CAGR of 3.50% from 2018 to 2028 here

News-ID: 1136190 • Views:

More Releases from Fact.MR

Elevators Market to Grow at 11% CAGR, Reaching $270 Billion by 2033
Elevators Market to Grow at 11% CAGR, Reaching $270 Billion by 2033
The international elevators market (エレベーター市場) got to an evaluation of United States $ 95 billion in 2023 as well as is predicted to get to United States $ 270 billion by the end of 2033. This market is anticipated to expand at a substantial CAGR of 11% from 2023 to 2033. The elevators market stands as a crucial cog in the wheel of contemporary facilities, promoting upright mobility in significantly metropolitan
Stone Paper Market Explosive Growth CAGR of 8.0% to Reach $2,096.9 Million by 2033
Stone Paper Market Explosive Growth CAGR of 8.0% to Reach $2,096.9 Million by 20 …
The international stone paper market (ストーンペーパーマーケット) is forecasted to get to an assessment of United States $ 972.6 million by the end of 2023 and also is anticipated to expand at a CAGR of 8.0% to get to United States $ 2,096.9 million by the end of 2033. The stone paper market is experiencing considerable development possibilities driven by raising need from the product packaging as well as publishing markets. Customer
Foliar Fertilizers Market Predicts 4% CAGR, $344 Million Expansion by 2029
Foliar Fertilizers Market Predicts 4% CAGR, $344 Million Expansion by 2029
The worldwide foliar fertilizers market is forecasted to accomplish a 4% ordinary substance yearly development price (CAGR) by the verdict of the projection duration. This development is anticipated to produce an increment chance of United States$ 344 million by the end of 2029. Foliar plant foods supply an useful choice for supplying nutrients to plants as they can be straight related to the fallen leaves. This approach not just improves nutrient
E-Compass Market $11.9 Billion Discovery By 2033 | Fact.MR
E-Compass Market $11.9 Billion Discovery By 2033 | Fact.MR
In 2023, the global E-Compass Market reached a valuation of US$ 2.6 billion, and projections indicate a substantial growth trajectory, with estimates soaring to US$ 11.9 billion by 2033. 𝗚𝗲𝘁 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝗽𝘆: https://www.factmr.com/connectus/sample?flag=S&rep_id=8417 This remarkable surge in market value is attributed to the anticipated surge in worldwide electronic compass sales, expected to surge at an impressive Compound Annual Growth Rate (CAGR) of 16.5% over the coming decade. The eCompass, an electric

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutics Market 2021 | Detailed Report
Global Parkinson’s Disease Therapeutics Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,